Imagen de Portada

Correction to “Pros and cons for statins use and risk of Parkinson’s disease: An updated perspective”

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Pharmacology Research & Perspectives
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease
por: Patricia Olar, et al.
Publicado: (2024)

Glutathione Decreases Parkinsonism‐Induced Ferroptosis and Oxidative Stress Through the Inhibition of the TRPM2 Channel in Neuronal Cells
por: Elif Güzel, et al.
Publicado: (2025)

Cross‐modal embedding integrator for disease‐gene/protein association prediction using a multi‐head attention mechanism
por: Munyoung Chang, et al.
Publicado: (2024)

HDAC4/5 Inhibitor, LMK‐235 Improves Animal Voluntary Movement in MPTP‐Induced Parkinson's Disease Model
por: Heejin Lee, et al.
Publicado: (2025)

Food–drug interactions risk management: An emergent piece of pharmacovigilance systems
por: Ana Margarida Advinha, et al.
Publicado: (2024)

Antioxidant potential of chlorogenic acid in Age‐Related eye diseases
por: Yu Tang, et al.
Publicado: (2024)

Correction to “Repurposing the Antidepressant Sertraline: A Systematic Scoping Review of Its Anticancer Mechanisms”
Publicado: (2026)

Teaching an old drug new tricks: Regulatory insights for the repurposing of hemin in cardiovascular disease
por: Ashley L. Eadie, et al.
Publicado: (2024)

Effectiveness of edaravone in preventing contrast‐induced nephropathy in high‐risk patients undergoing coronary angiography: A randomized, double‐blind trial
por: Azam Esmailnejad, et al.
Publicado: (2024)

Novel dysregulated long non‐coding RNAs in the acute kidney injury‐to‐chronic kidney diseases transition unraveled by transcriptomic analysis
por: Bhupendra Puri, et al.
Publicado: (2024)

Improving Population Pharmacokinetic Modelling with Artificial Patients using Generative Artificial Intelligence
por: Verena Schöning, et al.
Publicado: (2026)

Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post‐marketing safety
por: Cheng Jiang, et al.
Publicado: (2024)

Evaluation and optimization of sample size of neonates and infants for pediatric clinical studies on cefiderocol using a model‐based approach
por: Daichi Yamaguchi, et al.
Publicado: (2024)

Treatment of [99mTc]Tc‐hydroxy‐diphosphonate ([99mTc]Tc‐HDP) extravasation using hyaluronidase
por: Kevin R. Doornhof, et al.
Publicado: (2024)

Real‐world treatment outcomes of immune checkpoint inhibitors used off‐label in oncology: A comprehensive cancer institution experience
por: Sandra Fontanals, et al.
Publicado: (2024)

Prediction of cell cycle distribution after drug exposure by high content imaging analysis using low‐toxic DNA staining dye
por: Kazuma Takeuchi, et al.
Publicado: (2024)

Expanding the use of real‐world data through the development of user‐friendly tools to support drug development: Example of an organ impairment dashboard
por: Bianca Vora, et al.
Publicado: (2024)

Asciminib, a novel allosteric inhibitor of BCR‐ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance
por: Naoki Okamoto, et al.
Publicado: (2024)

Bioequivalence and the food effect of macitentan/tadalafil 10/20 fixed‐dose combination tablets versus the use of single‐component tablets in healthy subjects
por: Jennifer Lynn Ford, et al.
Publicado: (2024)

In vitro screening of UGT2B10 in silico prioritized putative ligands from drugs used in the pediatric hematopoietic stem cell transplantation setting
por: Yahia Bennani, et al.
Publicado: (2024)

Development of a pharmaceutical science systematic review process using a semi‐automated machine learning tool: Intravenous drug compatibility in the neonatal intensive care setting
por: D. Thisuri N. De Silva, et al.
Publicado: (2024)

Identification and neuroprotective properties of NA‐184, a calpain‐2 inhibitor
por: Michel Baudry, et al.
Publicado: (2024)

The endocannabinoid system in appetite regulation and treatment of obesity
por: Marija Kurtov, et al.
Publicado: (2024)

The gut–brain axis in appetite, satiety, food intake, and eating behavior: Insights from animal models and human studies
por: Georgia S. Clarke, et al.
Publicado: (2024)

Pharmacokinetics, disposition, and biotransformation of the cardiac myosin inhibitor aficamten in humans
por: Donghong Xu, et al.
Publicado: (2024)

NMDA Receptor–Mediated Ca2+ Flux Attenuated by the NMDA Receptor/TRPM4 Interface Inhibitor Brophenexin
por: Jordan Casby, et al.
Publicado: (2024)

Nicotine addiction and the influence of life adversity and acute stress on PYY: Prediction of early smoking relapse
por: Amanda A. Miller, et al.
Publicado: (2024)

Cromolyn sodium and masitinib combination inhibits fibroblast‐myofibroblast transition and exerts additive cell‐protective and antioxidant effects on a bleomycin‐induced in vitro fibrosis model
por: Azize Yasemin Göksu, et al.
Publicado: (2024)

Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System
por: Ana Sofia Martins, et al.
Publicado: (2024)

The blockade of the TGF‐β pathway alleviates abnormal glucose and lipid metabolism of lipodystrophy not obesity
por: Wen‐Dong Xu, et al.
Publicado: (2024)

Jordanian community pharmacists' perceptions and experiences with continuing professional development – A comprehensive analysis
por: Saja A. Alnahar, et al.
Publicado: (2024)

The impact of phosphodiesterase‐5 inhibition or angiotensin‐converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload
por: Tereza Tykvartova, et al.
Publicado: (2024)

Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring
por: Ling Shu, et al.
Publicado: (2024)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
por: András Érszegi, et al.
Publicado: (2024)

Issue Information
Publicado: (2024)

Exogenous melatonin's effect on salivary cortisol and amylase: A randomized controlled trial
por: Praewpat Pachimsawat, et al.
Publicado: (2024)

Role of G protein‐coupled receptor kinases (GRKs) in β2‐adrenoceptor‐mediated glucose uptake
por: Seungmin Ham, et al.
Publicado: (2024)

Disposition of orally administered atuliflapon, a novel 5‐lipoxygenase‐activating protein inhibitor in healthy participants
por: Xue‐Qing Li, et al.
Publicado: (2024)

Probe substrates assay estimates the effect of polyphyllin H on the activity of cytochrome P450 enzymes in human liver microsomes
por: Erhao Wang, et al.
Publicado: (2024)

FDA regulatory considerations for oncology drug development
por: Hanlim Moon, et al.
Publicado: (2024)